1. Home
  2. Endocannabinoid System
  3. Cannabinoid Receptors
  4. TRPV1

TRPV1

CBD

Submitted by admin on Mon, 03/14/2016 - 13:14

CBD is the second most common cannabinoid from the plant of cannabis.

2AGE/Noladin

Submitted by Alberto on Tue, 05/30/2017 - 11:45

Suspected cannabinoid that binds to several cannabinoid receptors.

2AG

Submitted by Alberto on Tue, 05/30/2017 - 11:35
2AG is a major endocannabinoid produced from lipids in cellular membranes, mostly but not exclusively in response to cellular activity.

Anandamide

Submitted by Alberto on Tue, 05/30/2017 - 11:14

Anandamide was the first identified endocannabinoid, named after the Sanskrit 'ananda' for inner bliss. Anandamide is produced from lipids in cellular membranes throughout the body.

CBDV

Submitted by Alberto on Tue, 05/09/2017 - 18:14

CBDV is a non-psychoactive cannabinoid with anti-convulsant properties like its homolog CBD. It has also other potential therapeutic properties as antitumorigenic, anti-acne and antiemetic effects.

CBN

Submitted by Alberto on Thu, 05/04/2017 - 14:14

CBN is a cannabinoid with weak psycho-active properties and some therapeutic potential related to cancer, pain, ALS and eating disorders.

THCV

Submitted by Alberto on Mon, 04/10/2017 - 14:14

THCV is a phytocannabinoid analogous to THC.

TRPV1

Submitted by admin on Mon, 03/14/2016 - 13:14

TRPV1 is part of the transient receptor potential family and is one of the non-GPCR cannabinoid receptors. TRPV1 is involved in thermoregulation and pain detection (nociception).

CBG

Submitted by Alberto on Mon, 03/14/2016 - 13:14

CBG is a non-psychoactive cannabinoid with therapeutic potential in cancer, Huntington's Disease, eating disorders, gastrointestinal inflammation, glaucoma and Psoriasis.

Epilepsy

Submitted by admin on Mon, 03/14/2016 - 13:14

cannabinoids have excellent therapeutic potential in Epilepsy. In the brain, cannabinoids tend to keep neuronal activity wihtin acceptable boundaries.